Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Jakub Mensik overcame rain and an opponent chasing history when he stunned six-time champi
- KIPG: Son of a vegetable vendor, Bihar’s Jhandu Kumar eyes Worlds, 2028 Paralympics
- Hardik Singh credits hard work and team unity for receiving HI Midfielder of the Year award
- Djokovic, Alcaraz land in same half of Miami draw
- India to host 2nd Asian Yogasana Championships from March 29 to 31
- FA Cup: AFC Bournemouth secure 5-4 penalty shootout win vs Wolves to reach QF
Ramdev releases 'research paper' on Patanjali's 'Coronil' medicine for coronavirus Last Updated : 19 Feb 2021 02:00:21 PM IST Yoga Guru Ramdev has released a scientific research paper on the 'first evidence-based medicine for Covid-19 by Patanjali'. The medicine was launched here at an event which was presided by Union Health Minister Harsh Vardhan and Transport Minister Nitin Gadkari.
"Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme," said Patanjali in a statement.Under CoPP, Coronil can now be exported to 158 countries.Commenting on the development Swami Ramdev said, Coronil will help humanity while providing affordable treatment based on naturopathy.On the basis of presented data, the Ministry of Ayush has recognised Coronil Tablet as medicine for "supporting the measure in COVID-19."For Latest Updates Please-
Join us on
Follow us on
172.31.16.186